Senyurek, S. Et Al. 2023. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study. ONCOLOGY RESEARCH , vol.31, no.5 , 689-696.

Senyurek, S., Saglam, S., Saglam, E. K., Yanar, H., Gok, K., TAŞTEKİN, D., ... Akbas, C.(2023). Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study. ONCOLOGY RESEARCH , vol.31, no.5, 689-696.

Senyurek, Sukran Et Al. "Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study," ONCOLOGY RESEARCH , vol.31, no.5, 689-696, 2023

Senyurek, Sukran Et Al. "Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study." ONCOLOGY RESEARCH , vol.31, no.5, pp.689-696, 2023

Senyurek, S. Et Al. (2023) . "Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study." ONCOLOGY RESEARCH , vol.31, no.5, pp.689-696.

@article{article, author={Sukran Senyurek Et Al. }, title={Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study}, journal={ONCOLOGY RESEARCH}, year=2023, pages={689-696} }